statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BriaCell Therapeutics Corp. (NASDAQ:BCTX - Get Free Report) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling...

Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTX) Drops By 7.9%

BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics has entered a significant agreement with the University of Texas MD A...

BriaCell Partners to Propel Cancer Vaccine Development

Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell's novel off-the-shelf personalized cancer...

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

PHILADELPHIA and VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ( BriaCell or the Company ), a clinical-stage...

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ( BriaCell or the Company ), a clinical-stage...

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

Bria-Pros+ Activates Multiple Immune Cell Types

 Figure 1 shows that Bria-Pros+ activates a range of immune cells in a modified mixed lymphocyte reaction.

 Bria-Pros+ Activates...

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) ( BriaCell or the Company ), a clinical-stage...

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Figure 1

 Magnetic resonance imaging (MRI) of the orbital tumor. The top left MRI image shows the tumor in the right orbit behind the eye with the eye not being visible pre-treatment...

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with  Eye-Bulging  Metastatic Breast Cancer

BriaCell Therapeutics Corp. (NASDAQ:BCTX  Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest...

BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Large Decrease in Short Interest

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Volume	28,649.00
52-Wk High	$7.18
52-Wk Low	$2.01

Period	Estimated	Reported	Surprise	Result
Q3'24	-$0.55	--	--	N/A
Q2'24	-$0.20	-$0.71	-255.00%	MISSED
Q1'24	-$0.18	-$0.50	-177.78%	MISSED
Q4'23	-$0.43	--	--	N/A
Q3'23	-$0.32	--	--	N/A

BCTX BriaCell Therapeutics Corp

About

Feed

News

Earnings

Fundamentals